WOBURN, MA—March 28, 2006—Covaris, Inc. a privately held company founded in 1999 to develop instrument systems based on its patented, proprietary, biophysical technology platform, today announces that methodologies using Adaptive Focused Acoustics (AFA) technology will be presented at two upcoming European meetings this spring.

APRIL
European Laboratory Robotics Group (ELRIG) Meeting, Thursday, 27 April 2006 at Hinxton Hall, Conference Centre, Hinxton,

Cambridge, United Kingdom:

“Investigation & Optimization of Bacterial Cell Lysis Using Adaptive Focused Acoustics”
Martin Hibbs, Investigator, Gene Expression & Protein Biochemistry Department
GlaxoSmithKline

www.elrig.org

MAY
MipTEC- The 9th International Conference and Exhibition on Drug Discovery, Tuesday 9 May, 2006 at Congress Center,

Basel, Switzerland:

“High Frequency Acoustic Technology –Evaluation for Compound Mixing and Dissolution”
Zoe Blaxill, Computation and Structural Sciences
GlaxoSmithKline

www.miptec.com

About Covaris:
Covaris, Inc. is a privately held company founded in 1999 to develop instrument systems based on its proprietary, patent-pending, biophysical technology platform. The technology is based on focused acoustic energy and applications of shock wave physics for advanced and high-throughput applications in biology and medicine.

Contact:
Covaris, Inc.
14 Gill Street, Unit H
Woburn, Massachusetts
USA 01801-1721
Tel: +1 781-932-3959
Fax: +1 781-932-8705
e-mail: info@covarisinc.com


<< Index of News Releases